NCM
TMO icon

Northside Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Northside Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.1M Sell
32,685
-56
-0.2% -$33.3K 1.76% 15
2026
Q2 		$16.4M Buy
32,741
+9,519
+41% +$4.57M 1.34% 19
2026
Q1 		$11.4M Buy
23,222
+17,383
+298% +$9.43M 1% 33
2025
Q4 		$3.38M Hold
5,839
– – 0.29% 64
2025
Q3 		$2.83M Buy
5,839
+39
+0.7% +$18.2K 0.26% 68
2025
Q2 		$2.35M Buy
5,800
+5,280
+1,015% +$2.21M 0.18% 67
2025
Q1 		$259K Buy
520
+43
+9% +$23.3K 0.04% 99
2024
Q4 		$248K Hold
477
– – 0.07% 99
2024
Q3 		$295K Hold
477
– – 0.05% 83
2024
Q2 		$264K Buy
477
+20
+4% +$11.5K 0.05% 87
2024
Q1 		$265K Hold
457
– – 0.05% 89
2023
Q4 		$242K Buy
457
+1
+0.2% +$484 0.08% 93
2023
Q3 		$231K Hold
456
– – 0.05% 91
2023
Q2 		$238K Hold
456
– – 0.08% 85
2023
Q1 		$263K Sell
456
-49
-10% -$27.6K 0.07% 78
2022
Q4 		$278K Buy
+505
New +$268K 0.08% 73

Other funds holding TMO

SP
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Northside Capital Management's TMO Position: Q3 2026 in Review

Northside Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.17% in Q3 2026, selling an estimated $33.3K and leaving 32,685 shares worth $22.1M. The position accounts for 1.76% of the portfolio, ranked #15.

Northside Capital Management first reported a position in TMO in Q4 2022 and has held it in 16 quarters since. 176 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Northside Capital Management held 32,685 shares of Thermo Fisher Scientific worth $22.1M as of Q3 2026.
  • Northside Capital Management sold 56 Thermo Fisher Scientific shares in Q3 2026, an estimated $33.3K.
  • Thermo Fisher Scientific made up 1.76% of Northside Capital Management's portfolio in Q3 2026, its #15 holding.
  • Northside Capital Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 16 quarters since.
  • 176 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Northside Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.